200
Participants
Start Date
November 15, 2012
Primary Completion Date
October 1, 2013
Study Completion Date
October 8, 2013
National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda
National Cancer Institute (NCI)
NIH